Castrol India, Gland Pharma not eligible to enter F&O, NSE modifies previous order

The National Stock Exchange (NSE) will be excluding shares of Castrol India and Gland Pharma from the Futures & Options (F&O) segment starting January 31, a statement from the exchange said on January 24.

A circular modifying the previous intimation, dated January 7, was shared by NSE, citing incomplete 'eligibility criteria' as the reason behind the decision to exclude. "...it is being hereby informed that the below securities have not fulfilled one of the eligibility criteria as
on date," said NSE, naming Castrol India and Gland Pharma in its latest communication.

"Members are requested to note that the availability of the above two securities for trading in Futures & Options contracts with effect from January 31, 2025 stands withdrawn," the circular said. No further explanation has been shared as to what criteria was not fulfilled, leading to the withdrawal from the segment.

Previously, NSE had proposed to include six companies, including these two, in the F&O space for trading from January 31, 2025. There is no change for other four securities, namely, NBCC, Phoenix, Solar Industries India and Torrent Power, as mentioned in the circular earlier.